Symposium 3: Lifestyle changes vs. pharmacological or surgical therapy in children and adolescents
DOI:
https://doi.org/10.47196/diab.v54i3Sup.280Keywords:
obesity, children, teenagersAbstract
Symposium 3: Obesity and diabetes
Lifestyle changes vs. pharmacological or surgical therapy in children and adolescents
Treatment for obesity in the pediatric age has as a goal to achieve the adequacy of weight, prevent or improve the comorbidities and maintain suitable growth and development, improving health and the quality of life in the long term. Changes in lifestyles, which include changes in alimentation, the increase of physical activity and strategies to modify behaviors, are the fundamental base of the treatment.
Although the magnitude of the weight loss produced is small, holding these changes during growth can lead to the adequacy of the size-weight relation through time. Even still without a significant weight loss, changes in lifestyle can pose an improvement to risk factors and the metabolic and functional comorbidities that tend to come with the risks. Children or adolescents with severe or complex obesity must be treated by specialized interdisciplinary pediatricians, who are able to provide an integral and intensive obesity treatment, who can evaluate and treat comorbidities and who are able to consider and decide regarding the use of pharmacological and surgical adjuvant therapy.
References
- Elvsaas I, et al. Multicomponent Lifestyle Interventions for Treating Overweight and Obesity in Children and Adolescents: A Systematic Review and Meta-Analyses. Journal of Obesity 2017; https://doi.org/10.1155/2017/5021902.
- Kelly A, et al. Working Toward Precision Medicine Approaches to Treat Severe Obesity in Adolescents: Report of an NIH Workshop Int J Obes (Lond). 2018; 42(11): 1834–1844.
- Ryder JR, et al. Treatment options for severe obesity in the pediatric population: Current limitations and future opportunities. Obesity 2018; 26: 951-960.
- Armstrong S, et al. Pediatric Metabolic and Bariatric Surgery: Evidence, Barriers, and Best Practices. Pediatrics. 2019;144(6):e20193223.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.